Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Adial Pharmaceuticals saw its stock rise after new FDA policy commentary suggested the agency may accept one adequate and well-controlled clinical investigation with confirmatory evidence in place of two independent pivotal trials when scientifically appropriate. The shift, described in a New England Journal of Medicine commentary, could reduce Pha…
Mizuho has maintained an Outperform rating and a $60.00 price target on PayPal Holdings Inc. after reports that the company has attracted takeover interest. The bank highlighted that PayPal is trading at a low multiple versus its recent historical average and emphasized the company’s scale across payments and digital wallets. Several other brokers …
European Central Bank President Christine Lagarde told an audience in Washington that Europe does not need to lead in frontier AI model development to reap economic rewards. Instead, she argued the region can capture significant gains by embedding AI across manufacturing and industrial processes — areas where European firms already show relative st…
A Royal Gold Inc. director sold just over $1.16 million of company stock on February 20, 2026, while the miner reported a fourth-quarter earnings shortfall but revenue that beat estimates. The shares have rallied sharply over the past year and are trading close to their 52-week peak, prompting investor attention as analysts weigh the latest financi…
Shares of Pure Storage fell sharply after the company unveiled a corporate name change to Everpure and announced a definitive agreement to acquire 1touch, a provider of data intelligence and orchestration tools. The rebrand is intended to reflect a move beyond traditional storage into broader data management capabilities. The transaction is expecte…
Christine Zedelmayer, Senior Vice President and Chief Operating Officer of Equillium, sold 185,937 shares of common stock on February 19, 2026 under a pre-arranged 10b5-1 plan, receiving proceeds of $328,104. On the same day she exercised options to acquire 185,937 shares at exercise prices of $0.73 and $0.785 for a combined cost of $141,749. After…
We upgrade SK Telecom to bullish on the view that management is near a decision point: a credible path to resume dividends and accelerate monetization of network and AI-related assets. The combination of yield appeal and clearer capital allocation could re-rate the stock. We lay out an actionable position with entry, stop and target levels and a li…
<p>Klarna has been a market talk candidate for a strategic re-rating if it can prove better-than-expected margins and sustained engagement in merchant partnerships. With live market data not available in the snapshot, this trade is conditional: a tactical long on a confirmed breakout with defined entry, stop and target. The risk/reward looks compel…
Genprex Inc. saw a sharp jump in its stock price after receiving patent grants from the Japanese Patent Office and the European Patent Office protecting combinations of its REQORSA gene therapy with immune checkpoint inhibitors. The Japanese patent covers REQORSA with PD-L1 antibodies, while the European patent covers REQORSA with PD-1 antibodies. …
Jefferies raised its 12-month price target on Chemours Co. (NYSE: CC) to $17 from $14 while retaining a Hold rating, citing support from the company's Opteon product line despite weaker-than-expected fourth-quarter results and cautious near-term guidance. Chemours reported Q4 EBITDA of $128 million, missed consensus and Jefferies' forecasts by $13 …
Jefferies has increased its price target on Lithium Americas Corp. (NYSE:LAC) to $8.00 from $7.00 while retaining a Buy rating. The new target implies substantial upside from the current share price level, amid a production ramp tied to Phase I of the Thacker Pass project and apparent offtake alignment with General Motors. Company disclosures on 20…
Brookline Capital Markets raised its price target on C4 Therapeutics (CCCC) from $20 to $30 while retaining a Buy rating, citing progress in cemsidomide development and clearer timing for upcoming trials. The firm pointed to the anticipated start of the Phase II MOMENTUM trial and higher confidence in a Phase 1b combination study with Pfizer's elra…
Davis Barry E, a director at Kirby Corp (NYSE: KEX), sold 8,480 shares on February 19, 2026, for $1,089,764 while simultaneously exercising options to acquire the same number of shares. The stock sale occurred with Kirby trading near a 52-week high after a recent 30% rally. Kirby reported fourth-quarter 2025 earnings that beat per-share estimates b…
Amy D. Husted, Executive Vice President, General Counsel and Secretary of Kirby Corporation, sold 11,667 shares of KEX on February 20, 2026 for roughly $1.5 million and on the same day exercised options to buy 8,667 shares. The company reported a fourth-quarter 2025 EPS that beat estimates while missing on revenue, and named Tracy A. Embree to its …
Shares of Texas Pacific Land (NYSE: TPL) rose about 3% on Monday after KeyBanc increased its price target to $639. The brokerage cited a notable uptick in client inquiries in 2026, renewed investor focus on the company’s water business, and revised earnings estimates for 2026 and 2027 following a record fourth quarter for water sales.
Jefferies increased its price target on Fisher & Paykel Healthcare to NZD47.00 from NZD46.00 while keeping a Buy rating after the company raised fiscal 2026 guidance on January 31, 2026. Management now expects operating revenue of NZD2.3 billion and net profit after tax of NZD450-470 million, versus earlier revenue guidance of NZD2.17-2.27 billion …
S&P Global Ratings cut Ashland Inc.'s long-term corporate credit rating to BB from BB+ while keeping the outlook stable, attributing the move to a reassessment of the company's business risk profile and weaker credit metrics. The agency highlighted Ashland's deliberate reduction in scale over the past decade, a decline in consolidated revenue a…
Johnson & Johnson announced that the European Commission has authorized a subcutaneous formulation of Rybrevant (amivantamab) for dosing every three weeks and every four weeks in patients with advanced EGFR-mutated non-small cell lung cancer. The approval extends the drug's authorized administration routes to include subcutaneous injections for the…
Saba Capital Management, L.P. — identified as a ten-percent owner of the PIMCO Dynamic Income Strategy Fund (NYSE: PDX) — executed two block sales totaling 56,991 shares for about $1.16 million. The trades took place on February 19 and 20, 2026, at prices just above the fund's current market quote. After the disposals, Saba still retains an indirec…
Citigroup is reportedly nearing an agreement to sell a 24% stake in its Mexican retail unit Grupo Financiero Banamex to a consortium of investors that includes Blackstone, according to people familiar with the matter. The potential transaction follows a 25% stake sale last year to a company controlled by Fernando Chico Pardo and his family. Citi de…
Starfighters Space Inc. saw its stock decline 14.4% following the resignation of founder Rick Svetkoff from his roles as Chief Executive Officer, President, Chairman and Director. The company also announced the resignation of Brenda Svetkoff as company secretary and the appointment of Tim Franta as CEO. Franta has led development of the STARLAUNCH …
Saba Capital Management, L.P., a roughly 10% holder of BlackRock ESG Capital Allocation Term Trust (ECAT), sold 75,148 shares of the trust's common stock on February 19 and 20, 2026. The transactions generated $1.13 million in proceeds at prices between $15.03 and $15.07 per share. After the sales, Saba Capital indirectly holds 23,669,210 shares of…
The U.S. Food and Drug Administration released draft guidance outlining a regulatory pathway for individualized therapies that directly target known genetic, cellular or molecular causes of disease. The guidance, produced jointly by the Center for Biologics Evaluation and Research and the Center for Drug Evaluation and Research, focuses on genome e…
U.S. President Donald Trump announced a new 15% global tariff after the Supreme Court struck down his broader levies last week. The move has immediate market effects - domestic lumber-related stocks dropped on Monday amid fears of cheaper imports, while analysts see potential benefits for certain retailers, emerging market assets and select consume…
Grey has expanded its business banking platform to include USD corporate accounts, bulk payment capabilities and support for the USDC stablecoin. The move is intended to let businesses receive international payments, manage cross-border transactions and reduce costs tied to traditional international banking, with payouts available to more than 170 …
